Home / Import refusals / SCS-5025720-6/11/1

FDA Import Refusal SCS-5025720-6/11/1 — Ipsen BioPharm Ltd

Ipsen BioPharm Ltd — FEI 1000346340

The FDA refused shipment SCS-5025720-6/11/1 from Ipsen BioPharm Ltd (United Kingdom) on December 14, 2022. The refused product falls under Drugs and Biologics — BOTOX. Cited charges: 118,3280,75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
December 14, 2022
Country
United Kingdom
Product Category
Drugs and Biologics
Product Code
65QCY02 BOTOX
Charges
118,3280,75

Recent inspections

  • 1283174 (VAI Thu May 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1117834 (VAI Fri Apr 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1059005 (VAI Fri Jul 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1026364 (VAI Tue Sep 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 965116 (VAI Wed Jan 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • AEK-0694787-2/10002/1B (Thu Jul 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • SCS-7226896-1/20002/1 (Tue Jun 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-0374978-4/10002/1 (Thu Apr 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-8270049-1/11/1 (Tue Apr 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-4998630-8/11/1 (Fri Apr 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources